1 Min Read
Feb 28 (Reuters) - RepliCel Life Sciences Inc
* RepliCel Life Sciences Inc - RepliCel signs two key service partnerships for final prototype manufacturing and testing of its dermal injector Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.